Cargando…

Serum C-reactive protein to albumin ratio and mortality associated with peritoneal dialysis

BACKGROUND: Serum C-reactive protein to albumin ratio (CAR) was recently identified as a poor marker of prognosis among various populations. The current study aimed to examine the association between CAR and all-cause mortality among patients undergoing peritoneal dialysis (PD). METHODS: A total of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Siyi, Qiu, Panlin, Luo, Laimin, Jiang, Lei, Chen, Yanbing, Yan, Caixia, Zhan, Xiaojiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946068/
https://www.ncbi.nlm.nih.gov/pubmed/32602387
http://dx.doi.org/10.1080/0886022X.2020.1783680
_version_ 1783662979631284224
author Liu, Siyi
Qiu, Panlin
Luo, Laimin
Jiang, Lei
Chen, Yanbing
Yan, Caixia
Zhan, Xiaojiang
author_facet Liu, Siyi
Qiu, Panlin
Luo, Laimin
Jiang, Lei
Chen, Yanbing
Yan, Caixia
Zhan, Xiaojiang
author_sort Liu, Siyi
collection PubMed
description BACKGROUND: Serum C-reactive protein to albumin ratio (CAR) was recently identified as a poor marker of prognosis among various populations. The current study aimed to examine the association between CAR and all-cause mortality among patients undergoing peritoneal dialysis (PD). METHODS: A total of 758 patients with PD were included in this study during the period from 1 November 2005 to 28 February 2017 and followed up until 31 May 2017. The primary outcome was all-cause mortality. We used multivariate Cox proportional hazard models and Kaplan-Meier survival curves to assess the relationship between CAR and all-cause mortality in these patients. RESULTS: Among 758 participants, mean age was 49.1 ± 14.2 years, with 56% males and 18.6% prevalence of diabetes. Median CAR was 0.13 (interquartile range [IQR], 0.07–0.34). After 27 months (IQR, 14–40 months) of follow-up, 157 deaths had been reported. After adjusting for confounding factors, we found a significant association between serum CAR and all-cause mortality among those in the highest CAR group (hazard ratio 1.91, 95% confidence interval 1.05– 3.47, p = 0.034). CONCLUSIONS: In patients undergoing PD, an increase in serum CAR is independently associated with increased risk for all-cause mortality.
format Online
Article
Text
id pubmed-7946068
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-79460682021-03-22 Serum C-reactive protein to albumin ratio and mortality associated with peritoneal dialysis Liu, Siyi Qiu, Panlin Luo, Laimin Jiang, Lei Chen, Yanbing Yan, Caixia Zhan, Xiaojiang Ren Fail Clinical Study BACKGROUND: Serum C-reactive protein to albumin ratio (CAR) was recently identified as a poor marker of prognosis among various populations. The current study aimed to examine the association between CAR and all-cause mortality among patients undergoing peritoneal dialysis (PD). METHODS: A total of 758 patients with PD were included in this study during the period from 1 November 2005 to 28 February 2017 and followed up until 31 May 2017. The primary outcome was all-cause mortality. We used multivariate Cox proportional hazard models and Kaplan-Meier survival curves to assess the relationship between CAR and all-cause mortality in these patients. RESULTS: Among 758 participants, mean age was 49.1 ± 14.2 years, with 56% males and 18.6% prevalence of diabetes. Median CAR was 0.13 (interquartile range [IQR], 0.07–0.34). After 27 months (IQR, 14–40 months) of follow-up, 157 deaths had been reported. After adjusting for confounding factors, we found a significant association between serum CAR and all-cause mortality among those in the highest CAR group (hazard ratio 1.91, 95% confidence interval 1.05– 3.47, p = 0.034). CONCLUSIONS: In patients undergoing PD, an increase in serum CAR is independently associated with increased risk for all-cause mortality. Taylor & Francis 2020-06-30 /pmc/articles/PMC7946068/ /pubmed/32602387 http://dx.doi.org/10.1080/0886022X.2020.1783680 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Liu, Siyi
Qiu, Panlin
Luo, Laimin
Jiang, Lei
Chen, Yanbing
Yan, Caixia
Zhan, Xiaojiang
Serum C-reactive protein to albumin ratio and mortality associated with peritoneal dialysis
title Serum C-reactive protein to albumin ratio and mortality associated with peritoneal dialysis
title_full Serum C-reactive protein to albumin ratio and mortality associated with peritoneal dialysis
title_fullStr Serum C-reactive protein to albumin ratio and mortality associated with peritoneal dialysis
title_full_unstemmed Serum C-reactive protein to albumin ratio and mortality associated with peritoneal dialysis
title_short Serum C-reactive protein to albumin ratio and mortality associated with peritoneal dialysis
title_sort serum c-reactive protein to albumin ratio and mortality associated with peritoneal dialysis
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946068/
https://www.ncbi.nlm.nih.gov/pubmed/32602387
http://dx.doi.org/10.1080/0886022X.2020.1783680
work_keys_str_mv AT liusiyi serumcreactiveproteintoalbuminratioandmortalityassociatedwithperitonealdialysis
AT qiupanlin serumcreactiveproteintoalbuminratioandmortalityassociatedwithperitonealdialysis
AT luolaimin serumcreactiveproteintoalbuminratioandmortalityassociatedwithperitonealdialysis
AT jianglei serumcreactiveproteintoalbuminratioandmortalityassociatedwithperitonealdialysis
AT chenyanbing serumcreactiveproteintoalbuminratioandmortalityassociatedwithperitonealdialysis
AT yancaixia serumcreactiveproteintoalbuminratioandmortalityassociatedwithperitonealdialysis
AT zhanxiaojiang serumcreactiveproteintoalbuminratioandmortalityassociatedwithperitonealdialysis